Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Mylan Keeps Options Open As Perrigo Pursuit Continues

This article was originally published in The Pink Sheet Daily

Executive Summary

After Teva dropped its offer for Mylan, the generic drug maker says it is exploring all options as it continues to pursue Perrigo. In the meantime, it has increased its ability to acquire its target through a tender offer.

Advertisement

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register